1. Organización Panamericana de la Salud (2013) Tratamiento antirretroviral bajo la lupa: un análisis de salud pública en Latinoamérica y el Caribe 2013. [cited 2014; Available from: http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=23711+&Itemid=999999&lang=es .
2. Ministerio de Salud de la Nación (2013) Boletín sobre el VIH-sida e ITS en Argentina, Buenos Aires. [cited 2014; Available from: http://www.msal.gov.ar/images/stories/bes/graficos/0000000325cnt-2014-01_sintesis-boletin-VIH-2013.pdf .
3. Crabtree-Ramirez B, Caro-Vega Y, Shepherd BE, Wehbe F, Cesar C, et al. Cross-sectional analysis of late HAART initiation in Latin America and the Caribbean: late testers and late presenters. PLoS One. 2011;6(5):e20272.
4. Mocroft A, Horban A, Clotet B, d’Arminio Monforte A, Bogner JR, et al. Regional differences in the risk of triple class failure in European patients starting combination antiretroviral therapy after 1 January 1999. HIV Med. 2008;9(1):41–6.
5. Mgbere O, Khuwaja S, Bell TK, Rodriguez-Barradas MC, Arafat R, et al. System and Patient Barriers to Care among People Living with HIV/AIDS in Houston/Harris County, Texas: HIV Medical Care Providers’ Perspectives. J Int Assoc Provid AIDS Care. 2014. doi: 10.1177/2325957414539045 .